AP
Alnylam Pharmaceuticals Inc
🇺🇸XNAS.ALNYUnited StatesHealthcare
$239.49USDup +1.18 (+0.5%)ClosedDelayed10:56 PM
FzScore
betaAnalysis is in beta - data may have gaps.
54/ 100
- Poor0-34
- Weak35-49
- Fair50-64
- Strong65-79
- Excellent80-100
Calculated Jun 28, 2026 - Next rebalance Jul 5, 2026 - Coverage 100%
Category radar
How to read
Each axis is a scored category from 0 to 100; a larger footprint is better and an unscored axis collapses to the centre.